Edesa Biotech (EDSA) Receivables - Other (2013 - 2022)

Edesa Biotech has disclosed Receivables - Other across 3 years of filings, most recently posting $1.1 million for Q3 2022.

• In Q3 2022, Receivables - Other fell 63.7% year-over-year to $1.1 million; the TTM figure through Sep 2022 stood at $1.1 million (down 63.7% YoY), while the FY2022 annual figure was $1.1 million, down 63.7% from the prior year.
• Receivables - Other came in at $1.1 million for Q3 2022 at Edesa Biotech, roughly flat from $1.1 million in the prior quarter.
• In the past five years, Receivables - Other ranged from a high of $4.0 million in Q2 2021 to a low of $1.1 million in Q1 2022.